Tle1 attenuates hepatic ischemia/reperfusion injury by suppressing NOD2/NF-κB signaling

References

• Peralta C, Jimenez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59(5):1094–1106.
   PubMed Web of Science ®Google Scholar
• Gracia-Sancho J, Casillas-Ramirez A, Peralta C. Molecular pathways in protecting the liver from ischaemia/reperfusion injury: a 2015 update. Clin sci. 2015;129(4):345–362.
   PubMed Web of Science ®Google Scholar
• Jia JJ, Li JH, Jiang L, et al. Liver protection strategies in liver transplantation. Hbpd Int. 2015;14(1):34–42.
   Google Scholar
• Qin JJ, Mao W, Wang X, et al. Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1. J Hepatol. 2018;69(5):1110–1122.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Petrowsky H, Hong JC, et al. Ischaemia-reperfusion injury in liver transplantation–from bench to bedside. Nat Clin Pract Gastroenterol Hepatol. 2013;10(2):79–89.
   Google Scholar
• Normand S, Waldschmitt N, Neerincx A, et al. Proteasomal degradation of NOD2 by NLRP12 in monocytes promotes bacterial tolerance and colonization by enteropathogens. Nat Commun. 2018;9(1):5338.
   PubMedGoogle Scholar
• Ting JP, Duncan JA, Lei Y. How the noninflammasome NLRs function in the innate immune system. Science (New York, NY). 2010;327(5963):286–290.
   Google Scholar
• Liu H, Wei X, Kong L, et al. NOD2 is involved in the inflammatory response after cerebral ischemia-reperfusion injury and triggers NADPH oxidase 2-derived reactive oxygen species. Int J Biol Sci. 2015;11(5):525–535.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang H, Liu LX, et al. NOD2 contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and inflammation. Life Sci. 2016;149:10–17.
   PubMed Web of Science ®Google Scholar
• Jennings BH, Ish-Horowicz D. The Groucho/TLE/Grg family of transcriptional co-repressors. Genome Biol. 2008;9(1):205.
   PubMed Web of Science ®Google Scholar
• De Paoli F, Copin C, Vanhoutte J, et al. Transducin-like enhancer of split-1 is expressed and functional in human macrophages. FEBS Lett. 2016;590(1):43–52.
   PubMed Web of Science ®Google Scholar
• Nimmo ER, Stevens C, Phillips AM, et al. TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn’s disease. Gastroenterology. 2011;141(3):972–981.e1-2.
   PubMed Web of Science ®Google Scholar
• Abe Y, Hines IN, Zibari G, et al. Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. Free Radic Biol Med. 2009;46(1):1–7.
   PubMed Web of Science ®Google Scholar
• Wang X, Mao W, Fang C, et al. Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression. J Hepatol. 2017;68(1):118–129.
   Web of Science ®Google Scholar
• Terry J, Saito T, Subramanian S, et al. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol. 2007;31(2):240–246.
   PubMed Web of Science ®Google Scholar
• Ramasamy S, Saez B, Mukhopadhyay S, et al. Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-kappaB inflammatory pathway. Proc Natl Acad Sci U S A. 2016;113(7):1871–1876.
   PubMed Web of Science ®Google Scholar
• Body-Malapel M, Dharancy S, Berrebi D, et al. NOD2: a potential target for regulating liver injury. Lab Invest. 2008;88(3):318–327.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhu T, Liu W, et al. TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury. J Mol Med (Berl). 2015;93(9):1033–1043.
   PubMed Web of Science ®Google Scholar
• Chen L, Kong L, Wei X, et al. beta-arrestin 2 negatively regulates NOD2 signalling pathway through association with TRAF6 in microglia after cerebral ischaemia/reperfusion injury. J Cell Mol Med. 2019;23(5):3325–3335.
   PubMed Web of Science ®Google Scholar
• Perez-Chanona E, Muhlbauer M, Jobin C. The microbiota protects against ischemia/reperfusion-induced intestinal injury through nucleotide-binding oligomerization domain-containing protein 2 (NOD2) signaling. Am J Pathol. 2014;184(11):2965–2975.
   PubMed Web of Science ®Google Scholar
• Mukherjee T, Hovingh ES, Foerster EG, et al. NOD1 and NOD2 in inflammation, immunity and disease. Arch Biochem Biophys. 2019;670:69–81.
   PubMed Web of Science ®Google Scholar
• Kersse K, Bertrand MJ, Lamkanfi M, et al. NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev. 2011;22(5–6):257–276.
   PubMed Web of Science ®Google Scholar
• Platnich JM, Muruve DA. NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways. Arch Biochem Biophys. 2019;670:4–14.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang J, Mulholland M, et al. mTOR activation protects liver from ischemia/reperfusion-induced injury through NF-kappaB pathway. Faseb J. 2017;31(7):3018–3026.
   PubMed Web of Science ®Google Scholar
• Shin T, Kuboki S, Lentsch AB. Roles of nuclear factor-kappaB in postischemic liver. Hepatol Res. 2008;38(5):429–440.
   PubMed Web of Science ®Google Scholar
• Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007;27(4):549–559.
   PubMed Web of Science ®Google Scholar
• Uehara T, Bennett B, Sakata ST, et al. JNK mediates hepatic ischemia reperfusion injury. J Hepatol. 2005;42(6):850–859.
   PubMed Web of Science ®Google Scholar
• Yan ZZ, Huang YP, Wang X, et al. Integrated omics reveals tollip as an regulator and therapeutic target for hepatic ischemia-reperfusion injury in mice. Hepatology. 2019;70(5):1750–1769.
   PubMed Web of Science ®Google Scholar
• Jimenez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, et al. Mitogen activated protein kinases in steatotic and non-steatotic livers submitted to ischemia-reperfusion. Int J Mol Sci. 2019;20:7.
   Web of Science ®Google Scholar